The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results from KEYNOTE-055: Pembrolizumab after platinum and cetuximab failure in head and neck squamous cell carcinoma (HNSCC).
 
Joshua Bauml
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Merck
Research Funding - Carevive Systems (Inst); Merck (Inst)
 
Tanguy Y. Seiwert
Honoraria - Amgen; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Merck; Merck Serono
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst)
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; Exelixis; Genentech; GlaxoSmithKline; Lilly; MedImmune; Merck; Novartis
 
Francis P. Worden
Honoraria - Bayer
Consulting or Advisory Role - Bayer/Onyx
Travel, Accommodations, Expenses - Bayer/Onyx
 
Stephen V. Liu
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Genentech; Perthera
 
Jill Gilbert
No Relationships to Disclose
 
Nabil F. Saba
No Relationships to Disclose
 
Jared Weiss
Consulting or Advisory Role - AstraZeneca; Biodesix; Clovis Oncology; EMD Serono; Lilly; OncoPlex Diagnostics
Research Funding - Astellas Pharma (Inst); Celgene (Inst); MedImmune (Inst); Merck (Inst); novartis (Inst); Pfizer (Inst)
 
Lori J. Wirth
Consulting or Advisory Role - Ashion Analytics; Eisai; Loxo; Merck
 
Ammar Sukari
Speakers' Bureau - Novartis
Research Funding - Acceleron Pharma; AstraZeneca; Boehringer Ingelheim; Karyopharm Therapeutics; Lilly; Mallinckrodt; MedImmune; Merck; VentiRx
 
Hyunseok Kang
Honoraria - AstraZeneca
Research Funding - Advaxis; AstraZeneca; Boehringer Ingelheim; ImmunoGen; Merck; Plexxikon; VentiRx
 
Michael K. Gibson
No Relationships to Disclose
 
Erminia Massarelli
Honoraria - Nektar
Consulting or Advisory Role - Nektar
Research Funding - AstraZeneca; Bristol-Myers Squibb; MedImmune; Merck
 
Steven Francis Powell
Research Funding - Merck Sharp & Dohme
 
Amy Meister
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Xinxin Shu
Employment - Merck
 
Jonathan D. Cheng
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Robert I. Haddad
Consulting or Advisory Role - Bayer; Celgene; Eisai; Merck
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)